Top Alzheimer's Diagnostics companies

The 19 key players our Alzheimer's Diagnostics report profiles, and other companies free public records show in this market.

Key players in Alzheimer's Diagnostics

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Also active in Alzheimer's Diagnostics

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Top trial sponsors in Alzheimer's Diagnostics

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Eli Lilly and Company 20 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Bristol-Myers Squibb 12 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Eisai Co. 10 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Roche 8 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Luye Pharma Group Ltd. 4 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Green Valley (Shanghai) Pharmaceuticals Co., Ltd. 3 active trials on ClinicalTrials.gov (opens in a new tab)
  7. Alnylam Pharmaceuticals 3 active trials on ClinicalTrials.gov (opens in a new tab)
  8. Eidos Therapeutics 3 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Alzheimer's Diagnostics reports by place

All 33 places for Alzheimer's Diagnostics

Get the full Alzheimer's Diagnostics report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.